PeRioperative Optimization With Nutritional Supplements for Patients Undergoing GastRointEStinal Surgery for Cancer

Trial Status: Closed
Start Date: October, 2018
Expected Enrolment: 73
Type of Trial: Prevention
Protocol IDs: NCT03445260, 3988
Trial Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Primary Purpose: Prevention
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Trial Phase: N/A
Medical Conditions: Gastrointestinal Cancer
Drugs: N/A
Lead Sponsor: Hamilton Health Sciences Corporation
Sponsors/Study Groups: None specified
Type of Treatment:
  • Placebo
  • Other: Nutritional Supplements
Principal Investigator(s): Not Specified, .
Date posted on December 21, 2017
Last updated: September 7, 2021
This trial was imported from

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.


Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society